Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.

J Mol Med (Berl)

Department of Dermatology, University of Vienna Medical School, Austria.

Published: April 1997

Download full-text PDF	Source
http://dx.doi.org/10.1007/s001090050115	DOI Listing

Publication Analysis

phase study

study immunotherapy

immunotherapy metastatic

metastatic malignant

malignant melanoma

melanoma cancer

cancer vaccine

vaccine consisting

consisting autologous

autologous cancer

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!